Uganda targets domestic HIV cure production via Cana

Uganda has partnered with Canadian institutions to develop and manufacture HIV cure technologies domestically. This initiative, called Immune Equity, aims to shift Uganda from a recipient of global health innovations to a producer of affordable biomedical solutions.
Why it matters
Localizing the production of advanced medical treatments is a key strategy for improving healthcare equity and accessibility in developing nations.
Health: Uganda targets domestic HIV cure production via Cana
The article reports on a government partnership and policy goals neutrally.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in